Diagnosis and Management of Fetal Growth Restriction Online Course

This course is based on SMFM Consult Series #52: Diagnosis and Management of Fetal Growth Restriction, published in 2020 in the American Journal of Obstetrics and Gynecology, and presents SMFM’s recommendations about the diagnosis, surveillance, and management of FGR. 

After completing the course, the learner should be able to:

1. Explain why the terms fetal growth restriction (FGR) and small for gestational age (SGA) should not be used interchangeably.
2. Describe the variations in diagnostic criteria for FGR and summarize the evidence that supports SMFM’s diagnostic criteria.
3. List components of the initial workup after the diagnosis of early and late FGR.
4. Discuss the FGR surveillance methods recommended by SMFM and the rationale for their recommendation.
5. Describe the management and delivery options in the setting of FGR based on the results of umbilical artery Doppler velocimetry results.

This course is designated for a maximum of 7 AMA PRA Category 1 Credits™. Participants must complete the pretest, online course, and completion survey to obtain credits.

This course expires on July 17, 2025. 

Continuing Medical Education Credits

In support of improving patient care, this activity has been planned and implemented by Global Learning Collaborative (GLC) and the Society for Maternal-Fetal Medicine. GLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Global Learning Collaborative (GLC) designates this enduring activity for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The AMA PRA Category 1^TM credits from this activity are accepted by the AIUM for practice accreditation in Standard OB and Detailed First and Detailed Second/Third Trimester Ultrasound.

Disclosures

In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. SMFM mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

The following individuals in control of this course’s content have no relevant financial relationships to disclose:

Course Directors: 

Christina A. Herrera, MD, Orlando Health, Orlando, FL

Anthony Shanks, MD, Indiana University, Indianapolis, IN

Kathleen Scogna, Senior Director of Education, Society for Maternal-Fetal Medicine, Washington, DC

Faculty:

Lauren Carlos, MD, Central Dupage Hospital, St. Charles, IL

Reviewers:

Alfred Abuhamad, MD, Eastern Virginia Medical School, Norfolk, VA

Alison Cahill, MD, MSCI, University of Texas, Austin, TX

Christina Han, MD, Geffen School of Medicine, Los Angeles, CA

Juliana Martins, MD, Eastern Virginia Medical School, Norfolk, VA

Christian Pettker, MD, Yale University, New Haven, CT

Flint Porter, MD, University of Utah Health, Salt Lake City, UT

Kavitha Ram, MD, Metropolitan Hospital Center, New York, NY

Joanne Stone, MD, Mount Sinai Health System, New York, NY

The following individuals in control of this course’s content have the following relevant financial relationships to disclose:

Faculty:

Nathan Blue, MD, University of Utah Health, Salt Lake City, UT: Samsung Medison and Moderna—research grants

Andrea Edlow, MD, MSc, Massachusetts General Hospital, Boston, MA: Merck Pharmaceuticals, NIH, Simons Foundation—research grant; Mirvie, Inc.—consulting fees

Mishella Perez, RDMS, RDCS, FAIUM, Scripps Health, San Diego, CA: GE Healthcare—consulting fees

Andrea Shields, MD, MSCR, University of Connecticut, Avon, CT: AHQR and UConn Health CRISP grant--research; Baylor College of Medicine Maternal Cardiac Arrest Simulator--patent holder; additional disclosures in for membership in Varda5 LLS, patient safety consulting company and asset holder in Overlevende LLC

Reviewers:

Joseph Biggio, MD, MS, Ochsner Health, New Orleans, LA: Mirivie--research grant

Richard Burwick, MD, MPH, San Gabriel Valley Perinatal Medical Group, West Covina, CA

Lorraine Dugoff, MD, University of Pennsylvania, Philadelphia, PA: Labcorp, Natera—research grants; State of California Genetic Screening Program—consulting fees

Cynthia Gyamfi-Bannerman, MD, MS, University of California, San Diego, CA: NICHD, NHLBI—research grants; Hologic--lecturer

Lori Harper, MD, MSCI, Dell Medical School, University of Texas, Austin, TX: NIH, ANA--research grants

Heidi Leftwich, DO, University of Massachusetts, Worcester, MA: Worcester Foundation Grant, COVID-19 Pandemic Fund—research grant

Torri Metz, MD, University of Utah Health, Salt Lake City, UT: Pfizer—research grant; UpToDate—receives royalties

Mary Norton, MD, University of California, San Francisco, CA: Luna Genetics—consulting fees

Luis Pacheco, MD, University of Texas Medical Branch, Galveston, TX: Coagulant Therapeutics—consulting fees

Anthony Sciscione, MD, Christiana Care, Wilmington, DE: NIH, PCORI—research grant; Elsevier—consulting fees; receives royalties

Sindhu Srinivas, MD, MSCE, University of Pennsylvania, Philadelphia, PA: NIH, Huff Powell & Bailey LLC, Palladium Risk Retention Group—consulting fees